Insider trade

Director sold ~$222K of COCO shares in the open market

Traded Mar 18, 2026 · Filed Mar 19, 2026

Why it stands out

A board member of The Vita Coco sold $222K of The Vita Coco shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$221,980

Shares × reported transaction price

Timing vs results

28 days after results of Feb 18, 2026, 42 days before results of Apr 29, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−11.2%	−2.2%	−8.9%
30 days	−10.2%	+9.3%	−19.5%
90 days	+58.9%	+15.1%	+43.8%
180 days	+6.6%	+16.3%	−9.7%

Past results only. Not a forecast.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.54 to $57.77, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

6mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance6mo ago

6mo ago

Derivative exercise or conversion — not an open-market buy.